Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)
4.280
+0.120 (2.88%)
Jun 3, 2025, 2:45 PM CST
SHE:300194 Revenue
In the year 2024, Fuan Pharmaceutical (Group) had annual revenue of 2.39B CNY, down -9.68%. Fuan Pharmaceutical (Group) had revenue of 467.68M in the quarter ending March 31, 2025, a decrease of -42.22%.
Revenue
2.39B
Revenue Growth
-9.68%
P/S Ratio
2.13
Revenue / Employee
726.45K
Employees
3,292
Market Cap
5.09B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.39B | -256.28M | -9.68% |
Dec 31, 2023 | 2.65B | 226.01M | 9.33% |
Jan 1, 2023 | 2.42B | -31.40M | -1.28% |
Jan 1, 2022 | 2.45B | 84.80M | 3.58% |
Dec 31, 2020 | 2.37B | -412.40M | -14.83% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |